Kelly Giles is the Director of Commercial Strategy at Proxima CRO, a contract research organization supporting emerging drug and medical device companies.

With approximately 20 years of experience in clinical research, Kelly’s background spans CROs, clinical technology and operations, relationship management, and business development. He began his career on the operational side of clinical research, supporting and managing eClinical systems, trial workflows, site and sponsor training, and cross-functional study teams before moving into commercial and strategic roles.

At Proxima, he serves as a clinical research partner and operations connector, helping life science innovators clarify where they are in development, where they are trying to go, and what support they need to move forward. He is focused on meeting clients where they are and connecting them with fit-for-purpose regulatory, clinical, and operational guidance.

His relationship-driven, operations-minded approach to clinical and commercial strategy is grounded in clear communication, collaboration, and stakeholder alignment. Drawing on his experience in clinical operations, CRO services, and trial technologies, Kelly understands both the strategic and real-world considerations that shape successful development programs.

The University of North Carolina at Chapel Hill: Communications, B.A.